Basic Information
| LncRNA/CircRNA Name | SNHG16 |
| Synonyms | NA |
| Region | GRCh38_17:76557766-76565348 |
| Ensemble | ENSG00000163597 |
| Refseq | NR_038108 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | RT-qPCR |
| Sample | pancreatic cancer tissues,cell lines (BXPC3, CFPAC-1, Panc-1, and Capan-2) |
| Expression Pattern | up-regulated |
| Function Description | SN-HG16 acts as an oncogene in pancreatic carcinoma and promotes cell metastasis via sponging miR-200a-3p, which might be a novel therapeutic strategy in pancreatic carcinoma. |
| Pubmed ID | 32141539 |
| Year | 2020 |
| Title | LncRNA SNHG16 functions as an oncogene by sponging miR-200a-3p in pancreatic cancer |
External Links
| Links for SNHG16 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |